3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
4
Prostatic Diseases
1
Prostate Cancer Metastatic
1
Kidney Neoplasms
1
Genital Diseases, Male
1
Carcinoma, Renal Cell
1
Interventions
enzalutamide
2
cabazitaxel
2
Prednisone
2
Androgen Antagonists
2
fludrocortisone acetate
1
darolutamide
1
XRP6258
1
Radiosurgery
1
Pluvicto
1
Lutetium-177
1
Lutetium
1
Lenograstim
1
Hydrocortisone
1
Granulocyte Colony-Stimulating Factor
1
Docetaxel
1
Dexamethasone
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Prostate Cancer Metastatic
×
Pluvicto
×
Clear all
NCT06320067
2025-09-26
STAMPEDE2
University College, London
Phase 3
Recruiting
3,360 enrolled